News
Dr. Buckman has over 35 years of Emergency Medicine Experience and is currently a Physician with Team Health in Lodi, CA. He has served as Medical Director or Associate Medical Director in hospitals and institutions for over 20 years and has over 40 years of clinical experience. He has served as Medical Director in the […]
Cyrcadia, Inc. is pleased to announce the addition of Ed Wertzberger to the Board of Directors as we continue to focus on implementation of our aggressive growth strategy and Go-To-Market plan. Jim Holmes, Chairman of the Board, says, “We are pleased to have an executive join our Board who possesses extensive leadership and global experience. […]
Based on 2018 Go-To-Market plans, investment infusion is paramount in keeping on track and maintaining our accelerated pace. Our stakeholders have been essential in supporting our march to bring the most advanced Breast Health product to market. For those stakeholders holding “B” warrants, the warrants will expire December 31, 2018, meaning conversion to shares in […]
Three key partner relationships are in place to bring “Best of Breed” subject matter experts into the Cyrcadia Health, Go-To-Market sales launch plan: Consumer Marketing: Dupuis Marketing, Chicago: branding, packaging, social media advertising, and user experience design. “We develop and create business opportunities that establish new meaning for people–digging for deeper truths beyond commonly leveraged […]
New discoveries have been achieved with our artificial intelligence (AI) algorithms. Recalling the foundational basis for the Cyrcadia Health intellectual property and patent filings is five algorithms that analyze tissue temperature and circadian body rhythm disruptions over a time period (dynamic) to identify tissue abnormalities. “Recently, our AI software scientists have made new discoveries that […]
Cyrcadia, Inc. is pleased to announce the addition of Marly Heidkamp, Chief Operating Officer, R.N., MSEd to the executive team to focus on execution of the Go-to- Market plan. Jim Holmes, CFO, say, “We are pleased to have an operations executive join our team who possesses medical product management experience as well. We are confident […]
As Cyrcadia prepares to move to clinical markets, Matt Benardis, CEO; Jim Holmes, CFO; along with our Clinical Research associate (CRA) met with clinical trial investigators and administration at El Camino Hospital, in San Mateo, CA, to discuss previous participant follow-up and trial resumption with our modified clinical product and associated study protocol. Do note […]
February 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with […]
Cyrcadia, Inc. (CI) announced it has won two prestigious awards at the Cannes Lions International Festival of Creativity, a global event for the creative communications, marketing and advertising world. Held in Cannes, France and attended by over 10,000 delegates, Lion awards are considered the most coveted in the industry. The first award was a Bronze […]
Reno-based Lifeline Biotechnologies, Inc. (OTC PINK: LLBO) recently transferred breast cancer detection technology to Cyrcadia, Inc. in exchange for 4,670,000 shares of Cyrcadia, Inc. common stock and a $110,000 cash and $220,000 promissory note. The additional 4,670,000 shares added to Lifeline’s original 8,000,000 shares totals 12,670,000 shares. Lifeline’s ownership is increased to over 45 percent of Cyrcadia, Inc., making Lifeline Cyrcadia, Inc.’s […]
Cyrcadia, Inc.(CI) announced this week a strategic expansion to accelerate operations and market launch into Asia for early breast cancer monitoring. CI has entered into a License and Cooperation Agreement Cyrcadia Asia, Ltd. (CA), a newly formed company in Hong Kong which will serve as the base for the Asia market launch of CI’s proprietary […]
CYRCADIA HEALTH EXPANDS ADVISORY BOARD WITH NATIONALLY RECOGNIZED AUTHOR AND SPORTS BUSINESS ADVISOR MANDY ANTONIACCI Magazine Columnist, Sports Business Advisor and Advocate for Social Change Fills Key Position for Cyrcadia Reno, Nev. – June 2, 2016 – Cyrcadia Health, awarded the 2016 Gold Edison Award as Top Healthcare Wearable for its early breast cancer screening technology, is […]
Cyrcadia’s technology was recently featured and Columbus, Ohio’s WBNS-TV10, notifying the viewing public of the expansion of our clinical trials at The Ohio State University. We are pleased to have Dr. William Farrar’s support in this endeavor. Please have a look. ‘iTBra’ could be the key to early breast cancer detection.
Ground Breaking Wearable iTBra™ Technology Holds Promise for Early Breast Cancer
Detection
Vatsun Thirapatarapong November 3, 2015 8:47 am In Thailand, breast cancer is the number-one cancer killing women, averaging seven women dying per week. More than 19 million Thai women are now in risk of having breast cancer. Such statistics on the occurrence of breast cancer are terrifying, but incredible strides across all forms of cancer […]
Focus: Healthcare Goes Digital Setpember 2015 • Issue 26 • The Internet of Everything revolutionizes the healthcare industry Why Why your Next Bra Could Save Your Life http://newsroom.cisco.com/healthcare-goes-digital-sept2015
Focus on Wearable Devices to Improve Early Cancer Detection Screening
Early Detection Technology for Breast Cancer
Subscribe to News feed